Ying Liu

Anlotinib vs placebo as third- or further-line treatment for patients with small cell lung cancer: a randomised, double-blind, placebo-controlled Phase 2 study

Ying Cheng, Qiming Wang, Kai Li et al. · British Journal of Cancer · 2021 · 141 citations · Full text

Placebo-controlled Phase 2, Further-line Treatment, Medicine +9

Anlotinib for previously treated advanced or metastatic esophageal squamous cell carcinoma: A double‐blind randomized phase 2 trial

Jing Huang, Juxiang Xiao, Wentao Fang et al. · Cancer Medicine · 2021 · 112 citations · Full text

Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology

Ying Liu, Zheming Lu, Ruiping Xu et al. · Oncotarget · 2015 · 75 citations · Full text

The direct and indirect association of cervical microbiota with the risk of cervical intraepithelial neoplasia

Chaoting Zhang, Ying Liu, Weijiao Gao et al. · Cancer Medicine · 2018 · 69 citations · Full text

Cervical Intraepithelial Neoplasia, Dysbiosis, Pathogenic Microbiology +19

Whole-Genome Analysis of Human Papillomavirus Types 16, 18, and 58 Isolated from Cervical Precancer and Cancer Samples in Chinese Women

Ying Liu, Yaqi Pan, Weijiao Gao et al. · Scientific Reports · 2017 · 58 citations · Full text